Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GMAB | Copenhagen | DKK | Real-time | |
GMABc | BATS Europe | DKK | Delayed | |
GMAB | NASDAQ | USD | Real-time | |
0MGB | London | DKK | Real-time | |
GMAB | Vienna | EUR | Real-time |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Belt Hold Bullish | 15 | Current | |||
Belt Hold Bullish | 30 | Current | |||
Inverted Hammer | 1D | Current | |||
Completed Patterns | |||||
Bullish Engulfing | 1M | 1 | Mar 24 | ||
Morning Doji Star | 1M | 1 | Mar 24 | ||
Morning Star | 1M | 1 | Mar 24 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
Copenhagen | 1,971.0 | 0.0 | 0.0 | 16,039 | -1.18% | DKK | |||
BATS Europe | 1,994.00 | 1,974.00 | 2,014.00 | 0 | 0.00% | DKK | |||
NASDAQ | 28.33 | 28.00 | 28.74 | 242,491 | -0.70% | USD | |||
London | 1,972.50 | 1,942.50 | 2,029.00 | 607 | -1.20% | DKK | |||
Vienna | 266.00 | 262.80 | 266.00 | 0 | +0.00% | EUR |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
IAG | 165.16 | 166.45 | 162.15 | -4.64 | -2.73% | 4.43M | |||
EasyJet | 517.06 | 529.00 | 515.80 | -12.94 | -2.44% | 506.55K | 08:54:48 | ||
Rolls-Royce Holdings | 395.15 | 399.00 | 392.80 | -7.35 | -1.83% | 1.81M | 08:55:11 | ||
Lloyds Banking | 50.40 | 50.83 | 50.28 | -0.60 | -1.18% | 9.29M | 08:55:01 | ||
Ocado | 345.00 | 346.90 | 343.00 | -5.00 | -1.43% | 100.04K | 08:54:57 | ||
BP | 511.10 | 514.40 | 510.50 | -1.30 | -0.25% | 2.16M | 08:54:58 | ||
BAE Systems | 1,289.50 | 1,290.50 | 1,280.50 | +2.50 | +0.19% | 490.41K | 08:55:05 | ||
Centamin | 127.20 | 128.40 | 126.60 | -0.90 | -0.70% | 488.89K | 08:53:28 | ||
HSBC | 634.80 | 636.90 | 633.80 | -9.80 | -1.52% | 2.39M | 08:54:39 | ||
Barclays | 182.08 | 182.90 | 181.50 | -1.90 | -1.03% | 4.02M | 08:54:37 |
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse large B-cell lymphoma and chronic lymphocytic leukemia; and HexaBody-CD38 and GEN3017 for treating hematological malignancies. In addition, the company develops Inclacumab, which is in Phase 3 trial for vaso-occlusive crises; Camidanlumab tesirine to treat hodgkin lymphoma and solid tumors; JNJ-64007957 and JNJ-64407564 to treat MM; PRV-015 for treating celiac disease; Mim8 for treating haemophilia A; and Lu AF82422 for treating multiple system atrophy disease. It operates various active pre-clinical programs. The company has a commercial license and collaboration agreement with Seagen Inc. to co-develop tisotumab vedotin. It also has a collaboration agreement with argenx to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology; and AbbVie for the development of epcoritamab, as well as collaborations with BioNTech, Janssen, and Novo Nordisk A/S. Genmab A/S was founded in 1999 and is headquartered in Copenhagen, Denmark.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review